$0.38
-0.01 (-2.69%)
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,025.2% upside
Low Target
$6.79
Average Target
$8.08
High Target
$13.52
Current Price
$0.38
Current
$0.38
$0.38
Target
$8.08
$8.08
$6.79
$8.08 avg
$13.52
Scenario Analysis
Bear Case
$6.79
1,685.9%
Low target
Base Case
$8.08
+2,025.2%
Avg target
Bull Case
$13.52
+3,456.0%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.49
-84.7% from high
52-Week Low
$0.40
+-5.9% from low
Target vs 52W High
$8.08
+224.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |